Discover

RGEN
Repligen Corporation
177.33
1 x 161.83
1 x 191.76
bid
ask
-
1.38
0.77%
10:08 AM
timesize
Ytd8.22%
1y7.34%
174.90
day range
179.25
100.99
52 week range
198.87
Open178.30Prev Close178.71Low174.90High179.25Mkt Cap11.29B
Vol38.83KAvg Vol1.15MEPS0.73P/E243.66Forward P/E66.27
Beta1.08Short Ratio7.18Inst. Own106.72%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning10-2750-d Avg176.91200-d Avg144.351yr Est199.70
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-272026-090.46N/AN/AN/A
2026-07-282026-060.450.540.0920.81%
2026-05-052026-030.380.480.126.32%
2026-02-242025-120.440.490.0511.36%
2025-10-282025-090.420.460.049.52%
2025-07-292025-060.40.37-0.03-7.50%
Upgrade / Downgrade
DateFirmActionFromTo
2026-10-19Canaccord GenuityUpgradeHoldHold
2026-10-07BarclaysUpgradeOverweightOverweight
2026-09-09UBSUpgradeBuyBuy
2026-07-30Wells FargoUpgradeOverweightOverweight
2026-07-29JP MorganUpgradeOverweightOverweight
2026-07-07BenchmarkUpgradeHoldBuy
Profile
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2026-03-04BYLUND JAMESChief Operating Officer25.42KStock Award(Grant)
2026-05-13DAWES KAREN ADirector92.82KStock Award(Grant)
2026-10-05DOUGLASS BRIAN ROBBOfficer8.69KStock Award(Grant)
2026-07-15GARLAND JASON K.Chief Financial Officer18.83KSale
2026-03-04HUGHES VIOLETTAOfficer6.33KStock Award(Grant)
2025-11-12HUNT ANTHONY JOHNDirector83.70KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.5.38M962.34M9.54%
2026-06-29FMR, LLC3.33M594.51M5.89%
2026-06-29United Capital Financial Advisors, LLC2.79M498.72M4.94%
2026-06-29Vanguard Capital Management LLC2.41M430.90M4.27%
2026-06-29Vanguard Portfolio Management LLC2.31M413.32M4.10%
2026-06-29Maverick Capital Ltd.1.98M354.66M3.52%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-08-30iShares Trust-iShares Core S&P Mid-Cap ETF1.86M331.87M3.29%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.70M304.32M3.02%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.23M219.71M2.18%
2026-06-29T. Rowe Price New Horizons Fund, Inc.963.03K172.10M1.71%
2026-05-30MFS Series Trust IV-MFS Mid Cap Growth Fund862.37K154.11M1.53%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund709.04K126.71M1.26%